Bubendorf, Switzerland

Daniel Trachsel

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Bubendorf, CH (2011 - 2012)
  • Bern, CH (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Daniel Trachsel: Innovative Inventor from Bubendorf, CH**

Introduction

Daniel Trachsel is a distinguished inventor based in Bubendorf, Switzerland. With a total of four patents to his name, Trachsel's contributions to the field of pharmaceuticals are particularly noteworthy. His innovations focus on novel compounds that serve as potential medicaments, showcasing his commitment to advancing medical science.

Latest Patents

Among Daniel Trachsel's latest patents are groundbreaking inventions related to 2-aza-bicyclo derivatives. His first patent involves 2-aza-bicyclo[3.3.0]octane derivatives, which are described by their specific formula. These compounds and their pharmaceutically acceptable salts are proposed for use as medicaments, particularly as orexin receptor antagonists.

The second invention features novel 2-aza-bicyclo[3.1.0]hexane derivatives, also utilized as orexin receptor antagonists. Similar to the previous patent, this invention involves a detailed formula and posits these compounds as valuable candidates for pharmaceutical applications.

Career Highlights

Daniel Trachsel is currently affiliated with Actelion Pharmaceuticals Ltd., a prominent player in the pharmaceutical industry. His role within this innovative company positions him at the forefront of medical research and development, contributing to the creation of new therapeutic agents.

Collaborations

Throughout his career, Trachsel has had the opportunity to work alongside esteemed colleagues such as Hamed Aissaoui and Christoph Boss. Collaborating with talented professionals in the pharmaceutical field has likely enriched his research and innovative processes.

Conclusion

Daniel Trachsel continues to make significant strides in the field of pharmaceuticals through his inventive work and dedication to enhancing health outcomes. As a committed inventor, Trachsel's innovations hold great promise for future medical advancements, particularly in the realm of orexin receptor antagonism.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…